Abdolkarim Mahrooz

584 total citations
35 papers, 449 citations indexed

About

Abdolkarim Mahrooz is a scholar working on Clinical Biochemistry, Molecular Biology and Pharmacology. According to data from OpenAlex, Abdolkarim Mahrooz has authored 35 papers receiving a total of 449 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Clinical Biochemistry, 10 papers in Molecular Biology and 9 papers in Pharmacology. Recurrent topics in Abdolkarim Mahrooz's work include Paraoxonase enzyme and polymorphisms (18 papers), Apelin-related biomedical research (9 papers) and Cynara cardunculus studies (7 papers). Abdolkarim Mahrooz is often cited by papers focused on Paraoxonase enzyme and polymorphisms (18 papers), Apelin-related biomedical research (9 papers) and Cynara cardunculus studies (7 papers). Abdolkarim Mahrooz collaborates with scholars based in Iran, Italy and United Kingdom. Abdolkarim Mahrooz's co-authors include Ahad Alizadeh, Zahra Kashi, Anvarsadat Kianmehr, Mehryar Zargari, Mohammad Bagher Hashemi‐Soteh, Abouzar Bagheri, Adele Bahar, Ernesto Maddaloni, Raffaella Buzzetti and Giovanna Muscogiuri and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Neuroscience.

In The Last Decade

Abdolkarim Mahrooz

33 papers receiving 443 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Abdolkarim Mahrooz Iran 15 178 154 113 98 81 35 449
Helena Castañé Spain 10 48 0.3× 78 0.5× 25 0.2× 16 0.2× 26 0.3× 29 264
Mohd Yasir Khan India 9 248 1.4× 146 0.9× 161 1.4× 14 0.1× 20 0.2× 27 423
Chang-Hong Jiang China 9 30 0.2× 122 0.8× 30 0.3× 62 0.6× 10 0.1× 14 478
Surajeet Kumar Patra India 11 31 0.2× 63 0.4× 54 0.5× 25 0.3× 14 0.2× 24 383
Claude Vieu France 14 30 0.2× 235 1.5× 250 2.2× 15 0.2× 21 0.3× 20 716
Maeve Sheehan United States 7 17 0.1× 281 1.8× 27 0.2× 52 0.5× 15 0.2× 15 584
José M. Pellegrino Argentina 14 23 0.1× 126 0.8× 59 0.5× 28 0.3× 20 0.2× 34 562
Mitsuhisa Manabe Japan 11 36 0.2× 80 0.5× 201 1.8× 14 0.1× 14 0.2× 15 502
Lesley J. Hinks United Kingdom 9 78 0.4× 106 0.7× 13 0.1× 32 0.3× 49 0.6× 14 347
Bülent Şengül Türkiye 8 17 0.1× 376 2.4× 34 0.3× 38 0.4× 15 0.2× 15 486

Countries citing papers authored by Abdolkarim Mahrooz

Since Specialization
Citations

This map shows the geographic impact of Abdolkarim Mahrooz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Abdolkarim Mahrooz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Abdolkarim Mahrooz more than expected).

Fields of papers citing papers by Abdolkarim Mahrooz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Abdolkarim Mahrooz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Abdolkarim Mahrooz. The network helps show where Abdolkarim Mahrooz may publish in the future.

Co-authorship network of co-authors of Abdolkarim Mahrooz

This figure shows the co-authorship network connecting the top 25 collaborators of Abdolkarim Mahrooz. A scholar is included among the top collaborators of Abdolkarim Mahrooz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Abdolkarim Mahrooz. Abdolkarim Mahrooz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Mahrooz, Abdolkarim. (2024). Pleiotropic functions and clinical importance of circulating HDL-PON1 complex. Advances in clinical chemistry. 121. 132–171. 2 indexed citations
3.
Mahrooz, Abdolkarim, et al.. (2024). Altered expression of miR-375 and miR-541 in type 2 diabetes patients with and without coronary artery disease (CAD): the potential of miR-375 as a CAD biomarker. Journal of Diabetes & Metabolic Disorders. 23(1). 1101–1106. 3 indexed citations
4.
Kianmehr, Anvarsadat, Isabella Faraoni, Ömer Küçük, & Abdolkarim Mahrooz. (2021). Epigenetic alterations and genetic variations of angiotensin-converting enzyme 2 (ACE2) as a functional receptor for SARS-CoV-2: potential clinical implications. European Journal of Clinical Microbiology & Infectious Diseases. 40(8). 1587–1598. 9 indexed citations
5.
6.
Kianmehr, Anvarsadat, Durdi Qujeq, Abouzar Bagheri, & Abdolkarim Mahrooz. (2021). Oxidized LDL-regulated microRNAs for evaluating vascular endothelial function: molecular mechanisms and potential biomarker roles in atherosclerosis. Critical Reviews in Clinical Laboratory Sciences. 59(1). 40–53. 13 indexed citations
7.
Mahrooz, Abdolkarim, et al.. (2020). Improved risk assessment of coronary artery disease by substituting paraoxonase 1 activity for HDL-C: Novel cardiometabolic biomarkers based on HDL functionality. Nutrition Metabolism and Cardiovascular Diseases. 31(4). 1166–1176. 10 indexed citations
8.
Kianmehr, Anvarsadat, et al.. (2018). Enzymatic characterization of a NADH-dependent diaphorase from Lysinibacillus sp. strain PAD-91. Protein Expression and Purification. 146. 1–7. 2 indexed citations
9.
Qujeq, Durdi, et al.. (2018). Genotype and phenotype of salt-stimulated paraoxonase 1 (PON1) is associated with atherogenic indices in type 2 diabetes. Journal of Diabetes & Metabolic Disorders. 17(1). 1–10. 6 indexed citations
10.
11.
12.
Kianmehr, Anvarsadat, et al.. (2016). The Rapid and Sensitive Quantitative Determination of Galactose by Combined Enzymatic and Colorimetric Method: Application in Neonatal Screening. Applied Biochemistry and Biotechnology. 179(2). 283–293. 5 indexed citations
13.
Mahrooz, Abdolkarim. (2016). Pharmacological Interactions of Paraoxonase 1 (PON1): A HDL-Bound Antiatherogenic Enzyme. Current Clinical Pharmacology. 11(4). 259–264. 25 indexed citations
14.
Kianmehr, Anvarsadat, Abdolkarim Mahrooz, Morteza Oladnabi, et al.. (2016). Purification and Characterization of Recombinant Darbepoetin Alfa from Leishmania tarentolae. Molecular Biotechnology. 58(8-9). 566–572. 2 indexed citations
15.
Kashi, Zahra, Abdolkarim Mahrooz, Anvarsadat Kianmehr, & Ahad Alizadeh. (2016). The Role of Metformin Response in Lipid Metabolism in Patients with Recent-Onset Type 2 Diabetes: HbA1c Level as a Criterion for Designating Patients as Responders or Nonresponders to Metformin. PLoS ONE. 11(3). e0151543–e0151543. 29 indexed citations
16.
Kianmehr, Anvarsadat, et al.. (2015). Cloning and expression of codon-optimized recombinant darbepoetin alfa in Leishmania tarentolae T7-TR. Protein Expression and Purification. 118. 120–125. 6 indexed citations
17.
Kashi, Zahra, et al.. (2015). The variant organic cation transporter 2 (OCT2)–T201M contribute to changes in insulin resistance in patients with type 2 diabetes treated with metformin. Diabetes Research and Clinical Practice. 108(1). 78–83. 23 indexed citations
18.
19.
Mahrooz, Abdolkarim, et al.. (2014). The role of clinical response to metformin in patients newly diagnosed with type 2 diabetes: a monotherapy study. Clinical and Experimental Medicine. 15(2). 159–165. 26 indexed citations
20.
Mahrooz, Abdolkarim, et al.. (2012). Increased oxidized-LDL levels and arylesterase activity/HDL ratio in ESRD patients treated with hemodialysis. Clinical and investigative medicine. 35(3). E144–E151. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Helena Castañé Breakdown of academic impact, for papers by Mohd Yasir Khan Breakdown of academic impact, for papers by Chang-Hong Jiang Breakdown of academic impact, for papers by Surajeet Kumar Patra Breakdown of academic impact, for papers by Claude Vieu Breakdown of academic impact, for papers by Maeve Sheehan Breakdown of academic impact, for papers by José M. Pellegrino Breakdown of academic impact, for papers by Mitsuhisa Manabe Breakdown of academic impact, for papers by Lesley J. Hinks Breakdown of academic impact, for papers by Bülent Şengül
Rankless by CCL
2026